RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 23-33
  • New CEO takes over evolving drugmaker Bristol-Myers Squibb

    Drugmaker Bristol-Myers Squibb Co. has a new leader, Dr. Giovanni Caforio, who became CEO as the company's annual meeting in Plainsboro, New Jersey, ended Tuesday. Caforio is a physician — a rarity in the biopharmaceutical industry, where most...
  • W.Va. company admits distributing unapproved products

    An Eastern Panhandle company faces a maximum $250,000 fine after admitting that it distributed medical products without federal approval. Rebuilder Medical Technologies also faces up to five years of probation. The Jefferson County company pleaded guilty...
  • Why the execution drug shortage won't go away in Florida or elsewhere

    Why the execution drug shortage won't go away in Florida or elsewhere
    In a few weeks, the U.S. Supreme Court will hear Glossip vs. Gross, which examines the use of the drug midazolam in lethal injection executions. The case comes on the heels of an infamously gruesome 2014, a year that saw botched executions in Ohio,...
  • U.S. prescription drug spending jumps to record $374 billion

    U.S. prescription drug spending jumps to record $374 billion
    U.S. spending on prescription drugs soared last year, driven up primarily by costly breakthrough medicines, manufacturer price hikes and a surge from millions of people newly insured due to the Affordable Care Act. Spending rose 13 percent, the...
  • Bill on drug pricing would help state in figuring healthcare costs

    Bill on drug pricing would help state in figuring healthcare costs
    A new crop of specialty drugs holds great promise for treating or even curing some devastating diseases, but their high cost challenges health insurers and taxpayer-funded health programs. In California, Gov. Jerry Brown has asked for $300 million in...
  • Early sales of MannKind inhaled insulin drug disappoint Wall Street

    Early sales of MannKind inhaled insulin drug disappoint Wall Street
    Early sales of MannKind Corp.'s new inhaled insulin drug were less than expected, and the Valencia company's stock skidded to near a one-year low. French pharmaceutical company Sanofi, which is marketing the drug, Afrezza, in a partnership with...
  • FDA approves Westlake Village company's drug to reduce double-chin fat

    FDA approves Westlake Village company's drug to reduce double-chin fat
    The Food and Drug Administration has approved a Westlake Village company's injectable drug as a treatment to reduce double-chin fat in adults. Kythera Biopharmaceuticals Inc. said in a news release that injections of the drug have been shown in clinical...
  • Vertex says 1Q sales of cystic fibrosis drug grew 31 percent

    Vertex Pharmaceuticals Inc. said Wednesday that sales of its cystic fibrosis drug Kalydeco climbed 31 percent in the first quarter. Vertex gets almost all of its revenue from Kalydeco, the first drug designed to treat the genetic cause of the disease....
  • Mylan raises offer for Perrigo to $34.1B, or $232 per share

    Generic drugmaker Mylan raised its offer for over-the-counter medicines maker Perrigo Wednesday, but the Irish company again rejected Mylan's overture. Mylan said Wednesday it will pay $232.23 for each share of Perrigo in a mix of cash and stock, valuing...
  • Valeant raises outlook after completing purchase of Salix

    Valeant Pharmaceuticals International Inc. said Wednesday it turned a profit in the first quarter, and the Canadian drugmaker raised its forecasts for the year after completing more acquisitions. The company reported a profit of $73.7 million, or 21...
  • Mylan ups bid again for Irish-based drug manufacturer Perrigo; Perrigo quickly says no

    PITTSBURGH Generic drug giant Mylan Wednesday morning boosted its offer for Irish-based drugmaker Perrigo for the second time, just two days after harshly rejecting an unsolicited takeover offer from Israel-based Teva Pharmaceutical Industries. Perrigo...